Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rejive Dananandan

Rejive Dananandan

Rejive Dayanandan

Senior Clinical Trial Manager

Rejive joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2001, initially working on the SEARCH trial as a study administrator during the latter stages of recruitment.

He is currently one of the CTSU representatives on the Oxford Clinical Trials Units Operational Leads Group and the administrative co-lead on the EASi-KIDNEY.

He was involved in the setting up of sites in the UK region of HPS2-THRIVE trial to assist with the completion of recruitment and subsequently took on the role of Senior Clinical Trial Manager overseeing all administrative aspects of the international REVEAL trial within the UK region.

He was the lead administrator on the UK HARP-III trial and shortly after completion of that UK-based trial, was responsible for oversight of trial administration of the international EMPA-KIDNEY trial.